Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “intermediate”
A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00910858. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05243550. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
ClinicalTrials.gov study NCT01669434. IPD Sharing: NO. Countries: 1. Publications: 20.
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00619099. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3
ClinicalTrials.gov study NCT02951429. IPD Sharing: Not stated. Countries: 13. Publications: 2.
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk
ClinicalTrials.gov study NCT01314313. IPD Sharing: NO. Countries: 2. Publications: 24.
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT07152067. IPD Sharing: NO. Countries: 1. Publications: 4.
A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Trea
ClinicalTrials.gov study NCT03755518. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Proton Therapy for Low and Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT00693238. IPD Sharing: Not stated. Countries: 1. Publications: 26.
Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cyto
ClinicalTrials.gov study NCT02315625. IPD Sharing: NO. Countries: 1. Publications: 6.
Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate
ClinicalTrials.gov study NCT01314417. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions
ClinicalTrials.gov study NCT01657942. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) P
ClinicalTrials.gov study NCT03682536. IPD Sharing: Not stated. Countries: 26. Publications: 4.
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
ClinicalTrials.gov study NCT03113617. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02631070. IPD Sharing: Not stated. Countries: 11. Publications: 6.
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
ClinicalTrials.gov study NCT00813293. IPD Sharing: NO. Countries: 1. Publications: 2.
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor
ClinicalTrials.gov study NCT02426086. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
ClinicalTrials.gov study NCT00084747. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
ClinicalTrials.gov study NCT01720225. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13)
ClinicalTrials.gov study NCT04811092. IPD Sharing: YES. Countries: 27. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.